{
    "clinical_study": {
        "@rank": "23214", 
        "acronym": "ADEPT", 
        "arm_group": [
            {
                "arm_group_label": "Radiotherapy", 
                "arm_group_type": "Experimental", 
                "description": "Patients undergo postoperative IMRT once daily, 5 days a week, for 6 weeks.  The prescribed radiotherapy dose will be 60 Gy in 2 Gy once-daily fraction size (total of 30 fractions)"
            }, 
            {
                "arm_group_label": "Radiotherapy, cisplatin", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients undergo postoperative IMRT once daily, 5 days a week, for 6 weeks.  The prescribed radiotherapy dose will be 60 Gy in 2 Gy once-daily fraction size (total of 30 fractions)\nPatients also receive cisplatin 40 mg/m2 IV on Days 1, 8, 15, 22, 29, and 36 of radiation therapy (6 doses for a total of 240 mg/m2)."
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized clinical trial studies the intensity of adjuvant (\"helper\") therapy required\n      in p16 positive oropharynx cancer patients, who have had all known disease removed\n      surgically by a minimally  invasive approach, and who have extracapsular spread in their\n      lymph nodes. After the surgery, patients are randomized to receive either radiation alone,\n      or radiation and weekly cis-platinum during therapy. Patients are then followed for cancer,\n      functional and quality of life outcomes."
        }, 
        "brief_title": "Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer", 
        "completion_date": {
            "#text": "October 2021", 
            "@type": "Anticipated"
        }, 
        "condition": "Oropharyngeal Neoplasms", 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Oropharyngeal Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient must have histologically confirmed p16 positive squamous cell carcinoma of\n             the oropharynx (OPSCC).\n\n          -  Patient must have undergone transoral resection of their T1-4a oropharynx primary to\n             a negative margin, and a neck dissection(s).\n\n          -  Patient's disease must be pathological N-stage positive.\n\n          -  Patient's disease must show extracapsular spread (ECS) in their nodal metastasis\n             verified by central pathologist's review.\n\n          -  Patients with synchronous primaries are included.\n\n          -  Patients with unknown primaries are included if the diagnosis of a primary site in\n             the oropharynx is made during the surgery.\n\n          -  Patients with recent excisional node biopsies/neck dissections are included if\n             material is evaluable for extracapsular spread.\n\n          -  Patient must be \u2265 21 years of age.\n\n          -  ECOG performance status \u2264 2 (Karnofsky \u226560%).\n\n          -  Patients must have normal organ and marrow function as defined below:\n\n          -  leukocytes \u22653,000/mcL\n\n          -  absolute neutrophil count \u22651,500/mcL\n\n          -  platelets \u2265100,000/mcL\n\n          -  total bilirubin <1.5 X upper normal institutional limit\n\n          -  AST(SGOT)/ALT(SGPT) \u22642.5 X institutional upper limit of normal\n\n          -  creatinine within normal institutional limits OR\n\n          -  creatinine clearance \u226560 mL/min/1.73 m2 for patients with creatinine levels above\n             institutional normal\n\n          -  Patient (or legally authorized representative) must be able to understand and willing\n             to sign a written informed consent document.\n\n        Exclusion Criteria:\n\n          -  Patient must not have pathologically N stage negative disease.\n\n          -  Patient must not have outside nodal tissue from previous neck biopsy/neck dissections\n             in which ECS cannot be confirmed or denied.\n\n          -  Patient must not have a true unknown primary in which permanent section results are\n             negative for malignancy in completely excised ipsilateral oropharyngeal tissue\n             (palatine and lingual tonsil).\n\n          -  Patient must not have distant metastatic disease at presentation.\n\n          -  Patient must not have gross residual and/or microscopic disease present after surgery\n             including re-resection(s), per the operative and pathology report.\n\n          -  Patient must not have a history of prior invasive malignancy (except non-melanomatous\n             skin cancer) unless disease free for a minimum of 3 years; noninvasive cancers (for\n             example, carcinoma in situ of the oral cavity, larynx, breast or cervix are all\n             permissible) are permitted even if diagnosed and treated < 3 years ago.\n\n          -  Patient must not have had previous systemic chemotherapy for the study cancer. (Note:\n             prior chemotherapy for a different cancer is allowable).\n\n          -  Patient must not be receiving any other investigational agents.\n\n          -  Patient must not have had any prior radiotherapy to the region of the study cancer\n             that would result in overlap of radiation therapy fields\n\n          -  Patient must not have any life-threatening comorbid illnesses e.g. stroke with major\n             sequelae or myocardial infarction/ unstable angina within the preceding 3 months or\n             psychiatric illness/social situations that would limit compliance with study\n             requirements.\n\n          -  Patient must not be pregnant or breastfeeding.  If a woman of childbearing potential,\n             patient must agree to use medically acceptable forms of contraception.\n\n        Both men and women and members of all races and ethnic groups are eligible for this trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "496", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01687413", 
            "org_study_id": "201207059"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Radiotherapy", 
                    "Radiotherapy, cisplatin"
                ], 
                "intervention_name": "Intensity-modulated radiation therapy (IMRT)", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": "Radiotherapy, cisplatin", 
                "intervention_name": "Cisplatin", 
                "intervention_type": "Drug", 
                "other_name": "CACP, CDDP, CPDD, DDP, Neoplatin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Cisplatin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 15, 2014", 
        "link": {
            "description": "Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine", 
            "url": "http://www.siteman.wustl.edu"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Clinical Trials Office - All Mayo Clinic Locations", 
                    "phone": "507-538-7623"
                }, 
                "facility": {
                    "address": {
                        "city": "Scottsdale", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85259-5499"
                    }, 
                    "name": "Mayo Clinic Scottsdale"
                }, 
                "investigator": [
                    {
                        "last_name": "Matthew Zarka, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Kelly Curtis, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Samir Patel, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Michael Hinni, M.D.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "haugheyb@ent.wustl.edu", 
                    "last_name": "Bruce Haughey, MBChB", 
                    "phone": "314-362-0365"
                }, 
                "contact_backup": {
                    "email": "rowec@wudosis.wustl.edu", 
                    "last_name": "Casey Rowe, MS", 
                    "phone": "314-362-8547"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }, 
                    "name": "Washington University School of Medicine"
                }, 
                "investigator": [
                    {
                        "last_name": "Hiram Gay, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Wade Thorstad, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Douglas Adkins, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Tanya Wildes, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Loren Michel, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "James Lewis, Jr., M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Samir El-Mofty, Ph.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jason Diaz, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Parul Sinha, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Michael Stadler, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ravindra Uppaluri, M.D., Ph.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Brian Nussenbaum, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Randal Paniello, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jason Rich, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Bruce Haughey, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Lanis Hall, M.D., M.P.H.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Timothy Pluard, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Rebecca Chernock, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jay Piccirillo, M.D.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Baran.Sumer@UTSouthwestern.edu", 
                    "last_name": "Baran Sumer, M.D.", 
                    "phone": "214-648-2904"
                }, 
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75390"
                    }, 
                    "name": "UT Southwestern Medical Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Baran Sumer, M.D.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Joel Thibodeaux, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Randall Hughes, M.D.", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "David Gerber, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Matt Karpowicz, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Lucien Nedzi, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Saad Khan, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "John Yordy, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Larry Myers, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "John Truelson, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Joan Schiller, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Susie Chen, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Adjuvant De-escalation, Extracapsular Spread, P16+, Transoral (A.D.E.P.T.) Trial for Oropharynx Malignancy", 
        "overall_contact": {
            "email": "haugheyb@ent.wustl.edu", 
            "last_name": "Bruce Haughey, MBChB", 
            "phone": "314-362-0365"
        }, 
        "overall_contact_backup": {
            "email": "rowec@wudosis.wustl.edu", 
            "last_name": "Casey Rowe, MS", 
            "phone": "314-362-8547"
        }, 
        "overall_official": {
            "affiliation": "Washington University School of Medicine", 
            "last_name": "Bruce Haughey, MBChB", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Survival probability will be estimated by Kaplan-Meier analysis and survival curves for patients with adjuvant radiotherapy w and w/o chemotherapy will be compared by use of log-rank statistic.", 
                "measure": "Disease-free survival (DFS)", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Rate of patients with no recurrence at original oropharyngeal site or in the neck nodal basins.", 
                "measure": "Locoregional control", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01687413"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Assessed by biopsy or imaging-detected recurrent disease at sites away from the original primary and cervical zone.", 
                "measure": "Distant metastasis rates", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years"
            }, 
            {
                "description": "Defined as time from surgery to death from recurrent oropharyngeal cancer or treatment-related death.", 
                "measure": "Disease specific survival", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years"
            }, 
            {
                "description": "Assessed by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0.", 
                "measure": "Cumulative incidence of complications/acute toxicity", 
                "safety_issue": "Yes", 
                "time_frame": "4.5 months"
            }, 
            {
                "description": "Multiplicity corrected tests for trend (i.e., non-parametric Jonckehere-Terpstra test) used to compare patients with adjuvant radiotherapy w/ and w/o chemotherapy at single time points (study entry 1, 3, 6, 12 and 24 months).", 
                "measure": "Function and quality of life (QOL)", 
                "safety_issue": "No", 
                "time_frame": "Up to 24 months"
            }
        ], 
        "source": "Washington University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}